Quantum BioPharma Ltd
QNTM25.715USD
+2.015+8.50%
交易中 （美東）報價延遲15分鐘
69.72M總市值
虧損本益比TTM
關於 Quantum BioPharma Ltd 公司
Quantum BioPharma Ltd. 是一家總部位於加拿大的生物製藥公司。該公司致力於建立資產和生物技術解決方案組合，用於治療具有挑戰性的神經退行性疾病和代謝性疾病以及酒精濫用障礙，其候選藥物處於不同的開發階段。通過其全資子公司 Lucid Psycheceuticals Inc. (Lucid)，該公司專注於其先導化合物 Lucid-MS 的研發，這是一種獲得專利的新化學實體，用於預防和逆轉髓鞘降解，髓鞘降解是多發性硬化症的潛在機制。其 unbuzzd 飲料是一種專有的維生素和礦物質配方，有助於肝臟和大腦功能，從而緩解飲酒的影響並恢復正常的生活方式。它通過其全資子公司 FSD Strategic Investments Inc. 維持着戰略投資組合，該投資組合代表以住宅或商業地產爲抵押的貸款。
公司簡介
公司代碼QNTM
公司名稱Quantum BioPharma Ltd
上市日期May 29, 2018
CEODr. Lakshmi P. Kotra, Ph.D.
員工數量- -
證券類型Ordinary Share
年結日May 29
公司地址55 University Ave. , Suite 1003
城市TORONTO
上市交易所Canadian Securities Exchange - CSE Listed
國家Canada
郵編M5J 2H7
電話14168548884
網址https://www.quantumbiopharma.com/
公司代碼QNTM
上市日期May 29, 2018
CEODr. Lakshmi P. Kotra, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Zeeshan Saeed
Mr. Zeeshan Saeed
Executive Co-Chairman of the Board, President, Chief Executive Officer
Executive Co-Chairman of the Board, President, Chief Executive Officer
118.11K
+6.97%
Mr. Anthony Durkacz
Mr. Anthony Durkacz
Co-Executive Chairman of the Board
Co-Executive Chairman of the Board
106.76K
+0.66%
Mr. Donal Carroll, CPA
Mr. Donal Carroll, CPA
Chief Financial Officer
Chief Financial Officer
90.41K
+9.30%
Ashwini Joshi,
Ashwini Joshi,
Director of Pharmaceutical Development
Director of Pharmaceutical Development
--
--
Mr. Adnan Bashir
Mr. Adnan Bashir
Independent Director
Independent Director
--
--
Mr. Joseph L. Romano
Mr. Joseph L. Romano
Director
Director
--
--
Mr. Lawrence (Larry) Latowsky
Mr. Lawrence (Larry) Latowsky
Independent Director
Independent Director
--
--
Mr. Kevin Cassidy
Mr. Kevin Cassidy
Vice President - Quality of Lucid
Vice President - Quality of Lucid
--
--
Dr. Andrzej Chruscinski, M.D., Ph.D.
Dr. Andrzej Chruscinski, M.D., Ph.D.
Vice President - Clinical and Scientific Affairs
Vice President - Clinical and Scientific Affairs
--
-100.00%
Dr. Lakshmi P. Kotra, Ph.D.
Dr. Lakshmi P. Kotra, Ph.D.
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD Australia
Chief Executive Officer of Lucid, Director, President of FSD Biosciences and CEO of FSD Australia
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Zeeshan Saeed
Mr. Zeeshan Saeed
Executive Co-Chairman of the Board, President, Chief Executive Officer
Executive Co-Chairman of the Board, President, Chief Executive Officer
118.11K
+6.97%
Mr. Anthony Durkacz
Mr. Anthony Durkacz
Co-Executive Chairman of the Board
Co-Executive Chairman of the Board
106.76K
+0.66%
Mr. Donal Carroll, CPA
Mr. Donal Carroll, CPA
Chief Financial Officer
Chief Financial Officer
90.41K
+9.30%
Ashwini Joshi,
Ashwini Joshi,
Director of Pharmaceutical Development
Director of Pharmaceutical Development
--
--
Mr. Adnan Bashir
Mr. Adnan Bashir
Independent Director
Independent Director
--
--
Mr. Joseph L. Romano
Mr. Joseph L. Romano
Director
Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月25日 週五
更新時間: 7月25日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Malone Wealth Ventures LLC
21.76%
Saeed (Zeeshan)
3.10%
Durkacz (Anthony)
2.80%
Carroll (Donal)
2.37%
AdvisorShares Investments, LLC
1.28%
Other
68.68%
持股股東
持股股東
佔比
Malone Wealth Ventures LLC
21.76%
Saeed (Zeeshan)
3.10%
Durkacz (Anthony)
2.80%
Carroll (Donal)
2.37%
AdvisorShares Investments, LLC
1.28%
Other
68.68%
股東類型
持股股東
佔比
Investment Advisor
23.49%
Individual Investor
9.23%
Corporation
0.37%
Investment Advisor/Hedge Fund
0.22%
Hedge Fund
0.08%
Other
66.61%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
50
1.05M
34.28%
+341.83K
2025Q1
50
413.46K
17.05%
-229.58K
2024Q4
44
604.87K
28.35%
+138.76K
2024Q3
45
583.17K
30.09%
+414.87K
2024Q2
43
126.91K
14.87%
-21.03K
2024Q1
47
105.72K
14.06%
-57.49K
2023Q4
49
159.35K
26.32%
+20.22K
2023Q3
52
164.58K
27.23%
+48.13K
2023Q2
52
164.21K
27.10%
+38.85K
2023Q1
56
112.96K
18.07%
-21.18K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Malone Wealth Ventures LLC
610.37K
20.82%
+610.37K
--
Jun 23, 2025
Saeed (Zeeshan)
118.11K
4.03%
+7.69K
+6.97%
Apr 03, 2025
Durkacz (Anthony)
106.06K
3.62%
+7.69K
+7.82%
Apr 03, 2025
Carroll (Donal)
90.41K
3.08%
+7.69K
+9.30%
Apr 03, 2025
AdvisorShares Investments, LLC
48.99K
1.67%
-283.32K
-85.26%
Mar 31, 2025
Kotra (Lakshmi)
29.57K
1.01%
+7.69K
+35.15%
Apr 03, 2025
J.W. Cole Advisors, Inc.
12.59K
0.43%
+12.59K
--
Mar 31, 2025
Global X Investments Canada Inc.
8.24K
0.28%
-1.31K
-13.73%
Feb 29, 2024
Saeed (Rehan)
6.79K
0.23%
-2.15K
-24.09%
Dec 31, 2024
Xorax Family Trust
6.79K
0.23%
--
--
Dec 31, 2024
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
AdvisorShares Psychedelics ETF
9.02%
AdvisorShares Psychedelics ETF
佔比9.02%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
公告日期
類型
比率
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
Aug 12, 2024
Merger
65<1
